000 01128 a2200301 4500
005 20250515150634.0
264 0 _c20090313
008 200903s 0 0 eng d
022 _a1751-5521
024 7 _a10.1111/j.1751-553X.2008.01115.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAndrès, E
245 0 0 _aOral cobalamin (vitamin B(12)) treatment. An update.
_h[electronic resource]
260 _bInternational journal of laboratory hematology
_cFeb 2009
300 _a1-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aVitamin B 12
_xpharmacokinetics
650 0 4 _aVitamin B 12 Deficiency
_xdrug therapy
700 1 _aDali-Youcef, N
700 1 _aVogel, T
700 1 _aSerraj, K
700 1 _aZimmer, J
773 0 _tInternational journal of laboratory hematology
_gvol. 31
_gno. 1
_gp. 1-8
856 4 0 _uhttps://doi.org/10.1111/j.1751-553X.2008.01115.x
_zAvailable from publisher's website
999 _c18488321
_d18488321